New York State Common Retirement Fund’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
Other funds holding EIGR
SAM
6CM
UOC
RC
GCP
New York State Common Retirement Fund's EIGR Position: Q3 2023 in Review
New York State Common Retirement Fund sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q3 2023, closing a stake of 12 shares — an estimated $245 sold.
New York State Common Retirement Fund first reported a position in EIGR in Q2 2016 and held it in 21 quarters. The position peaked at $358K in Q4 2019. 51 funds tracked by Wall St. Rank hold EIGR as of Q3 2023.
- New York State Common Retirement Fund reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- New York State Common Retirement Fund sold 12 Eiger BioPharmaceuticals, Inc. shares in Q3 2023, an estimated $245.
- New York State Common Retirement Fund first reported a position in Eiger BioPharmaceuticals, Inc. in Q2 2016 and held it in 21 quarters.
- New York State Common Retirement Fund's Eiger BioPharmaceuticals, Inc. position peaked at $358K in Q4 2019.
- 51 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q3 2023.
Based on New York State Common Retirement Fund's 13F filing for Q3 2023, filed 7 Nov 2023.